GE Aerospace (NYSE:GE)
$ 163.38 -4.12 (-2.46%) Market Cap: 178.84 Bil Enterprise Value: 177.18 Bil PE Ratio: 53.57 PB Ratio: 5.99 GF Score: 63/100

General Electric Co Healthcare Investor Day at the RSNA Annual Meeting Transcript

Dec 02, 2019 / 02:30PM GMT
Release Date Price: $55.56 (-0.98%)
Steven Eric Winoker
General Electric Company - VP of Investor Communications

(presentation)

Good morning, everybody. What a great way to start with that video. Welcome to our GE Healthcare Investor Meeting, and especially thank you to those who braved the weather coming in from the East Coast and elsewhere to make it here. I know on some of you, it was not easy. So we appreciate it.

I'm Steve Winoker, VP of IR for GE, and I'm delighted to be in Chicago with the team here. We're joined by our Healthcare CEO, Kieran Murphy, and members of his leadership team upfront.

Before we start, I'd like to remind you that the presentation for today is available on our investor website. In the presentation, GE Healthcare, excluding biopharma financials and figures, reflect today's view of the business as internally reported within GE and of our best estimates prior to completion of the deal closing. We'll be saying very little about the biopharma business and deal today. As many of you know, Danaher is in the lead on the regulatory approvals. What we can say is that we remain on track for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot